Interfraction Interval in Patients With Stage III Non-Small-Cell Lung Cancer Treated With Hyperfractionated Radiation Therapy With or Without Concurrent Chemotherapy-Reference-Cited by-同舟云学术

Interfraction Interval in Patients With Stage III Non-Small-Cell Lung Cancer Treated With Hyperfractionated Radiation Therapy With or Without Concurrent Chemotherapy

Published:2004-12 Issue:6 Volume:27 Page:616-625
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Jeremic Branislav,Milicic Biljana,Dagovic Aleksandar,Aleksandrovic Jasna,Milisavljevic Slobodan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference40 articles.

1. Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approach

2. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

3. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

4. Radiotherapy in the management of locally advanced lung cancer of all cell types: Final report of randomized trial

5. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer;Decision Tools for Radiation Oncology;2013

2. Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients;Clinical and Translational Oncology;2012-07-12

3. Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy;Cancer;2011-01-10

4. Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer;Radiation Oncology;2007-12

5. Influence of Interfraction Interval on Local Tumor Control in Patients With Limited-Disease Small-Cell Lung Cancer Treated With Radiochemotherapy;International Journal of Radiation Oncology*Biology*Physics;2007-06